Insider Trading activities at Hi Tech Pharmacal Co Inc (HITK)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hi Tech Pharmacal Co Inc (HITK) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Hi Tech Pharmacal Co Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 887497.

Total stock buying since 2010: $0.
Total stock sales since 2010: $16,498,605.
Total stock option exercises since 2010: $6,634,105.

▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies


11 insiders reported insider trading activities at Hi Tech Pharmacal Co Inc (HITK):
Insider trading activities of Seltzer Reuben
Insider trading activities of Van Hulst Jack
Insider trading activities of April Gary M
Insider trading activities of Hirshaut Yashar
Insider trading activities of Harvey Bryce M
Insider trading activities of Peters William J
Insider trading activities of Goldwyn Martin M
Insider trading activities of Seltzer David S
Insider trading activities of Deerfield Special Situations Fund International Ltd
Insider trading activities of Simpson Bruce W
Insider trading activities of Egbaria Kamel

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Hi Tech Pharmacal Co Inc (HITK).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2013 0 $0 119,216 $5,075,950 302,385 $4,274,064
2012 0 $0 166,151 $5,349,695 112,060 $1,455,875
2011 0 $0 0 $0 193,845 $755,656
2010 0 $0 242,083 $6,072,960 17,813 $148,510

Table 2. Monthly summary of insider trading at Hi Tech Pharmacal Co Inc (HITK).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2013-12 0 $0 6,873 $295,951 6,873 $169,007
2013-10 0 $0 93,718 $4,041,074 145,718 $2,234,846
2013-09 0 $0 6,125 $263,925 24,794 $436,212
2013-02 0 $0 4,639 $176,282 4,639 $49,544
2013-01 0 $0 7,861 $298,718 120,361 $1,384,455
2012-12 0 $0 5,626 $199,385 5,626 $89,397
2012-11 0 $0 0 $0 14,082 $117,020
2012-10 0 $0 84,250 $2,771,680 14,671 $119,224
2012-08 0 $0 12,500 $443,750 12,500 $72,875
2012-07 0 $0 63,775 $1,934,880 65,181 $1,057,359
2011-11 0 $0 0 $0 168,750 $648,000
2011-10 0 $0 0 $0 25,095 $107,656
2010-12 0 $0 231,377 $5,853,125 0 $0
2010-10 0 $0 1,000 $21,220 4,802 $41,243
2010-09 0 $0 2,956 $60,390 6,261 $44,927
2010-07 0 $0 6,750 $138,225 6,750 $62,340

Table 3. Detailed insider trading at Hi Tech Pharmacal Co Inc (HITK)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-12-13 April Gary M (President, HCP Division) Sale 6,873 43.06 295,951
2013-12-13 April Gary M (President, HCP Division) Option Ex 6,873 24.59 169,007
2013-10-10 Seltzer Reuben (Vice Chairman, Business Dev't) Sale 11,250 43.13 485,212
2013-10-10 Seltzer Reuben (Vice Chairman, Business Dev't) Option Ex 11,250 10.93 122,962
2013-10-09 Seltzer David S (CEO, President, Sec'y, Treas.) Option Ex 75,000 14.99 1,124,250
2013-10-08 Seltzer David S (CEO, President, Sec'y, Treas.) Sale 23,000 43.09 991,070
2013-10-04 Goldwyn Martin M (Director) Sale 1,500 43.10 64,650
2013-10-04 Goldwyn Martin M (Director) Option Ex 1,500 24.95 37,425
2013-10-03 Peters William J (EVP & Chief Financial Officer) Sale 21,250 43.11 916,087
2013-10-03 Peters William J (EVP & Chief Financial Officer) Option Ex 21,250 12.35 262,437
2013-10-02 Simpson Bruce W (Director) Sale 10,100 43.14 435,714
2013-10-02 Seltzer Reuben (Vice Chairman, Business Dev't) Sale 11,250 43.13 485,212
2013-10-02 Seltzer Reuben (Vice Chairman, Business Dev't) Option Ex 11,250 13.50 151,875
2013-10-01 Simpson Bruce W (Director) Sale 15,368 43.15 663,129
2013-10-01 Simpson Bruce W (Director) Option Ex 25,468 21.04 535,897
2013-09-30 April Gary M (President, HCP Division) Sale 3,125 43.08 134,625
2013-09-30 April Gary M (President, HCP Division) Option Ex 3,125 32.59 101,843
2013-09-30 Goldwyn Martin M (Director) Option Ex 3,111 13.50 41,998
2013-09-27 Goldwyn Martin M (Director) Sale 3,000 43.10 129,300
2013-09-27 Goldwyn Martin M (Director) Option Ex 7,308 19.23 140,496
2013-09-17 Hirshaut Yashar (Director) Option Ex 11,250 13.50 151,875
2013-02-05 Peters William J (VP and Chief Financial Officer) Sale 36 38.00 1,368
2013-02-05 Peters William J (VP and Chief Financial Officer) Option Ex 36 10.68 384
2013-02-01 Peters William J (VP and Chief Financial Officer) Sale 4,603 38.00 174,914
2013-02-01 Peters William J (VP and Chief Financial Officer) Option Ex 4,603 10.68 49,160
2013-01-24 Peters William J (VP and Chief Financial Officer) Sale 7,861 38.00 298,718
2013-01-24 Peters William J (VP and Chief Financial Officer) Option Ex 7,861 10.68 83,955
2013-01-09 Seltzer David S (CEO, President, Sec'y, Treas.) Option Ex 112,500 11.56 1,300,500
2012-12-10 April Gary M (President, HCP Division) Sale 5,626 35.44 199,385
2012-12-10 April Gary M (President, HCP Division) Option Ex 5,626 15.89 89,397
2012-11-14 Goldwyn Martin M (Director) Option Ex 2,832 8.31 23,533
2012-11-05 Hirshaut Yashar (Director) Option Ex 11,250 8.31 93,487
2012-10-16 Van Hulst Jack (Director) Sale 3,000 32.75 98,250
2012-10-16 Van Hulst Jack (Director) Option Ex 3,000 5.83 17,490
2012-10-16 Goldwyn Martin M (Director) Option Ex 421 19.59 8,247
2012-10-16 Seltzer Reuben (Vice Chairman, Business Dev't) Sale 6,800 32.56 221,408
2012-10-16 Seltzer David S (CEO, President, Sec'y, Treas.) Sale 29,441 32.60 959,776
2012-10-15 Seltzer Reuben (Vice Chairman, Business Dev't) Sale 3,200 33.47 107,104
2012-10-15 Seltzer David S (CEO, President, Sec'y, Treas.) Sale 20,559 32.97 677,830
2012-10-12 Seltzer Reuben (Vice Chairman, Business Dev't) Sale 11,250 33.01 371,362
2012-10-12 Seltzer Reuben (Vice Chairman, Business Dev't) Option Ex 11,250 8.31 93,487
2012-10-11 Seltzer Reuben (Vice Chairman, Business Dev't) Sale 10,000 33.59 335,950
2012-08-15 Peters William J (VP and Chief Financial Officer) Sale 12,500 35.50 443,750
2012-08-15 Peters William J (VP and Chief Financial Officer) Option Ex 12,500 5.83 72,875
2012-07-17 Egbaria Kamel (Chief Scientific Officer, EVP) Sale 11,342 32.56 369,295
2012-07-17 Egbaria Kamel (Chief Scientific Officer, EVP) Option Ex 11,342 23.10 262,000
2012-07-17 April Gary M (President, HCP Division) Sale 10,624 32.41 344,323
2012-07-17 April Gary M (President, HCP Division) Option Ex 10,624 21.94 233,122
2012-07-17 Goldwyn Martin M (Director) Sale 401 32.05 12,852
2012-07-17 Goldwyn Martin M (Director) Option Ex 401 14.99 6,010
2012-07-16 Peters William J (VP and Chief Financial Officer) Sale 4,983 32.00 159,456
2012-07-16 Peters William J (VP and Chief Financial Officer) Option Ex 4,983 19.95 99,410
2012-07-16 Goldwyn Martin M (Director) Sale 5,956 30.97 184,457
2012-07-16 Goldwyn Martin M (Director) Option Ex 5,956 14.24 84,843
2012-07-13 April Gary M (President, HCP Division) Sale 10,000 29.35 293,470
2012-07-13 April Gary M (President, HCP Division) Option Ex 10,000 9.06 90,630
2012-07-13 Simpson Bruce W (Director) Sale 1,907 29.33 55,932
2012-07-13 Simpson Bruce W (Director) Option Ex 1,907 19.59 37,358
2012-07-13 Goldwyn Martin M (Director) Option Ex 1,406 8.31 11,683
2012-07-12 Simpson Bruce W (Director) Sale 18,562 27.75 515,095
2012-07-12 Simpson Bruce W (Director) Option Ex 18,562 12.52 232,303
2011-11-10 Seltzer Reuben (Director) Option Ex 56,250 3.84 216,000
2011-11-10 Seltzer David S (CEO, President, Sec'y, Treas.) Option Ex 112,500 3.84 432,000
2011-10-24 Seltzer Reuben (Director) Option Ex 11,250 4.29 48,262
2011-10-10 Goldwyn Martin M (Director) Option Ex 2,595 4.29 11,132
2011-10-06 Hirshaut Yashar (Director) Option Ex 11,250 4.29 48,262
2010-12-13 Deerfield Special Situations Fund International Ltd Sale 135,000 25.50 3,442,500
2010-12-10 Deerfield Special Situations Fund International Ltd Sale 95,177 25.00 2,379,425
2010-12-09 Deerfield Special Situations Fund International Ltd Sale 1,200 26.00 31,200
2010-10-06 Goldwyn Martin M (Director) Sale 1,000 21.22 21,220
2010-10-06 Goldwyn Martin M (Director) Option Ex 2,290 8.89 20,369
2010-10-05 Goldwyn Martin M (Director) Option Ex 2,512 8.31 20,874
2010-09-21 Goldwyn Martin M (Director) Option Ex 947 5.83 5,521
2010-09-20 Goldwyn Martin M (Director) Sale 1,000 20.84 20,840
2010-09-20 Goldwyn Martin M (Director) Option Ex 1,000 13.50 13,500
2010-09-16 Goldwyn Martin M (Director) Option Ex 2,358 1.92 4,527
2010-09-13 Goldwyn Martin M (Director) Sale 1,956 20.22 39,550
2010-09-13 Goldwyn Martin M (Director) Option Ex 1,956 10.93 21,379
2010-07-16 Harvey Bryce M (Officer) Sale 3,750 20.49 76,845
2010-07-16 Harvey Bryce M (Officer) Option Ex 3,750 7.88 29,550
2010-07-16 Goldwyn Martin M (Director) Sale 3,000 20.46 61,380
2010-07-16 Goldwyn Martin M (Director) Option Ex 3,000 10.93 32,790

Insider trading activities including stock purchases, stock sales, and option exercises of HITK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hi Tech Pharmacal Co Inc (symbol HITK, CIK number 887497) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.